Material guided drug delivery for pigmented villonodular synovitis using an implantable biomaterial and BIO-orthogonal chemistry
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA224561
- Recipient
-
Tambo, Inc. UEI KJ8KQCTJBL17
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $245,207
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- San Francisco, CA 94107, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$50,187 | |
| Original award | $295,394 |
Quick answers
Who received award R43CA224561?
R43CA224561 was awarded to Tambo, Inc. by National Cancer Institute (National Institutes of Health) on August 1, 2018.
How much is award R43CA224561 worth?
$245,207 has been obligated on R43CA224561.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award